That lung 20

A that lung dozen

Inhibition of Betaine-Homocysteine S-Methyltransferase Reasons Hyperhomocysteinemia that lung in Mice1,2

ABSTRACT



KEY WORDS: * betaine * homocysteine * that lung dimethylsulfoniopropionate





The objective of the studies declared here was to decide no matter if the inhibition of BHMT in vivo by potent and distinctive inhibitors of the enzyme would escalate fasting and post-Met load tHcy grades, and no matter if the instinctively taking place sulfonium analog of Bet, dimethylsulfoniopropionate (DMSP), will be a very effective post-Met load tHcy-lowering agent.

MATERIALS And techniques















Western blot diagnostic. Mouse liver extracts were probed for BHMT protein as described previously (21).



Statistics. For Studies 1-4, Student's t try on was used to run a test for diversities within the implies. For Learn 5, informations were assessed day nit exploiting 1-way ANOVA,, cure diversities were estimated exploiting Fisher's least-significant discrepancy procedure. All diversities are declared as SEM.

RESULTS



Result of CBHcy on tHcy. In Learn 1, CBHcy cure drastically grown tHcy grades and reduced BHMT activity at the 1, 2, 4, and eight h time points likened with saline-treated regulates (Fig. 1). By 24 h, BHMT activity and tHcy grades didn't vary amidst the two teams. The degree of BHMT protein wasn't measurably stricken by a singular CBHcy cure (Fig. 2). The degrees of MS and CBS performances, as analyzed trying the benchmark assays, didn't vary among treatments.



In Learn 3, CBHcy-treated rat had >2-fold taller tHcy grades than rat supervised Met solitary (128 ± 17 as opposed to. 40 ± 14 µmol/L;. As witnessed in Learn 1, BHMT activity was sharply inhibited within the CBHcy-treated rat likened with saline-treated regulates (not represented).



Result of alternative BHMT methyl sponsor on post-Met load tHcy. In Learn 5, rat supervised Confronted with isomolar degrees of Bet or DMSP had 69-82% reduce post-Met load tHcy emphasis than those given Met solitary (Fig. 4).

Dialog





It isn't known why the results of CBHcy are transient. It's possible which the medication is metabolized, and we tried to address its certainly likely transition to Hey within this report (spoken about below). It's also probable which CBHcy is purified by the kidney and excreted within the urine. An additional probability is which other tissues normally takes up the medication less quickly than liver and keep it for a longer time, hence piece by piece using up the liver of CBHcy. These and other potentials may just be estimated merely by more exhaustive pharmacokinetic testimonials of the medication, studies that appears to be unquestionably guaranteed.



Even though we were not able to identify any potency of liver or blood tissue to transform CBHcy to Hey in vitro, it was probable which few of the augment in tHcy afterwards CBHcy cure was as a result of CBHcy metabolic process which we were not able to identify. To address this concern, we estimated the results of CBHcy cure on tHcy grades in rat given a Met load in Learn 3. Our results supplied clean substantiation which CBHcy is functionally inhibiting BHMT at the 1-mg dosage and which BHMT has a significant role in attenuating the post-Met load uprise in tHcy. Rat given CBHcy in merger with a Met load had tHcy grades which were 88 µmol/L taller than those given Met solitary. If BHMT inhibition just weren't occurring,, as soon as the equivalent quantity of CBHcy was offered without a Met load (Fig. 1).





In closing, exploiting potent and selective inhibitors of BHMT, we declared the initial substantiation which a transient but elemental elimination of BHMT activity reasons a transient augment in both food-deprived and post-Met load tHcy in rat, and which BHMT is necessary to maintain quite typical degrees of AdoMet in liver. These informations propose that if mutations within the BHMT gene are learned that drastically lower BHMT function, so therefore people with 2 faulty alleles are going to possess some level of hyperhomocysteinemia and grown jeopardy for Hcy-related health issues. A scarcity of BHMT activity are going to unsurprisingly predispose the liver to fatty infiltration and other pathology, adding up hepatocellular carcinoma, as a result of the absence of AdoMet (29,31). As well as that, we indicated for the 1st time which a instinctively taking place sulfonium analog of Bet, DMSP, is an efficient post-Met load tHcy-lowering agent.

ACKNOWLEDGMENT

We thank Dr. Sandy Sluggish for her mechanic aid and for her support intending this manuscript.

[Sidebar]

that lung .

Manuscript earned 20 Jan 2006. Preliminary review concluded 8 Feb 2006. Revision approved 10 Parade 2006.

[Useful resource]

LITERATURE Quoted

1. Nygard O, Vollset Search engine, Refsum H, Brattstrom L, Ueland PM. Over all homocysteine and coronary disease. J Intern Mediterranean. 1999:246:425-54.

2. Mato JM, Lu SC. Homocysteine, the bad thiol. Hepatology. 2005;41:976-9.

3. Fowler B. Homocysteine: a review of biochemistry, molecular biology, and role in malady proceedings. Semin Bouquet Mediterranean. 2005;5:77-86.

4. Distress JJ, Dowey L. Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolic process and CVD. Proc Nutr Soc. 2004;63:597-603.

5. Yap S. Time-honored homocystinuria: vascular jeopardy and its deterrence. J Inherit Metab Dis. 2003:26:259-65.

6. Schwahn BC, Laryea MD, Chen Z, Melnyk S, Pogribny I, Garrow T, James SJ, Rozen R. Betaine rescue of an animal model with methylenetetrahydrofolate reductase defect. Biochem J. 2004:382:831-40.

7. da Costa KA, Gaffney CE, Fischer LM, Zeisel SH. Choline defect in rat and humans is linked with grown plasma homocysteine emphasis afterwards a methionine load. Am J Clin Nutr. 2005:81:440-4.

8. Olthof MR, Brink EJ, Katan MB, Verhoef P. Choline supplemented as phosphatidylcholine cuts down fasting and postmethionine-loading plasma homocysteine focuses in healthy men. Am J Clin Nutr. 2005:82:111-7.

9. Olthof MR, Verhoef P. Effects of betaine intake on plasma homocysteine focuses and aftermath for health. Curr Drug Metab. 2005:6:15-22.

10. Schwab U, Torronen A, Meririnne E, Saarinen M, Alfthan G, Aro A, Uusitupa M. By mouth supervised betaine has an acute and dose-dependent influence on emulsion betaine and plasma homocysteine focuses in healthy humans. J Nutr. 2006:136:34-8.

11. Sluggish S, Lever M, Shelter MB1 George PM, Chambers ST. Betaine analogues change homocysteine metabolic process in rodents, lnt J Biochem Cellular Biol. 2004:36:870-80.

. Yagisawa M, Okawa N, Shigematsu N, Nakata R. Effects of intravenous betaine on methionine-loading-induced plasma homocysteine elevation in rodents. J Nutr Biochem. 2004:15:666-71.

13. Heil SG, lievers KJ, Boers GH, Verhoef P, den Heijer M, Trijbels FJ, Blom HJ. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevancy to hyperhomocysteinemia and vascular malady in humans. MoI Genet Metab. 2000:71:511-9.

14. Fischer LM, Scearce JA, Mar MH, Patel JR, Blanchard RT, Macintosh BA, Busby MG, Zeisel SH. Advertisement libitum choline intake in healthy people meets or surpasses the proposed ample intake grade. J Nutr. 2005:135:826-9.

15. Garrow TA. Refinement, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J Biol Chem. 1996:271:22831-8.

16. Garcia AJ, Apitz-Castro R. Plasma over all homocysteine quantification: a growth of the time-honored high-performance liquid chromatographic strategy with fluorescence discovery of the thiol-SBD derivatives. J Chromatogr B Analyt Technol Biomed Life Sci. 2002:779:359-63.

17. Banerjee R, Chen Z. Gulati S. Methionine synthase from pig liver. Ways and means Enzymol. 1997:281:189-96.

18. Lambert BD, Titgemeyer EC, Stokka GL, DeBey BM, Loest CA. Methionine serve up to expanding steers influences hepatic performances of methionine synthase and betaine-homocysteine methyltransferase, but not cystathionine synthase. J Nutr. 2002:132:2004-9.

19. Taoka S, OhJa S, Shan X, Kruger WD, Banerjee R. Substantiation for hememediated redox legislation of human cystathionine beta-synthase activity. J Biol Chem. 1998:273:25179-84.

20. Vina J, Gimenez A, Puertes IR, Gasco E, Vina that lung JR. Incapability of cysteine synthesis from methionine in rodents disclosed to operative tension. Br J Nutr. 1992:68:421-9.

21. Delgado-Reyes Curriculum vitae, day nit Garrow TA. High salt chloride intake cuts down betaine-homocysteine S-methyltransferase expression in guinea pig liver and kidney. Am J Physiol Regul lntegr Comp Physiol. 2005;288:R182-7.

22. Wang W. Kramer PM, Yang S, Pereira Mum, Tao L. Reversed-phase highperformance liquid chromatography process of the simultaneous willpower of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the actual result of methionine on their focuses. J Chromatogr B Biomed Sci Appl. 2001:762:59-65.

23. Awad WM Jr, Whitney PL, Skiba WE, Mangum JH, Wells MS. Substantiation for lead methyl exchange in betaine: homocysteine S-methyl-transferase. J Biol Chem. 1983:258:12790-2.

24. Fromm HJ, Nordlie Radio control. On the refinement and kinetics of mice liver thetinhomocysteine transmethylase. Arch Biochem Biophys. 1959:81:363-76.

25. Finkelstein JD, Harris BJ, KyIe WE. Methionine metabolic process in mammals: kinetic learn of betaine-homocysteine methyltransferase. Arch Biochem Biophys. 1972:153:320-4.

26. Castro C, Gratson AA, Evans JC, Jiracek J, Collinsova M, Ludwig ML, Garrow TA. Dissecting the catalytic appliances of betaine-homocysteine S-methyltransferase by utilization of intrinsic tryptophan fluorescence and site-directed mutagenesis. Biochemistry. 2004:43:5341-51.

27. Evans JC, Huddler DP, Jiracek J, Castro C, Millian NS, Garrow TA, Ludwig ML. Betaine-homocysteine methyltransferase: zinc in a distorted barrel. Structure. 2002:10:1159-71.

28. Castro C, Breksa AP Third, Salisbury EM, Garrow TA. Betaine-homocysteine S-methyltransferase transcription is inhibited by S-adenosylmethionine. In: Milstien S, Kapatos G, Levine RA, Shane B. publishers. 12th Multinational Symposium on Pteridines and Folates; Bethesda, MD: Kluwer Tutorial; 2002. p. 549-56.

29. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila Mum, Kanel G, Mato JM. Methionine adenosyltransferase 1A knockout rat are predisposed to liver casualty and showcase grown expression of genes engaged in expansion. Proc Natl Acad Sci U . s .. 2001:98:5560-5.

30. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. Rat insufficient in cystathionine beta-synthase: animal versions for mild and harsh homocyst(e)inemia. Proc Natl Acad Sci U . s .. 1995:92:1585-9,

31. Mato JM, Corrales FJ, Lu SC, Avila Mum. S-Adenosylmethionine: a control switch which controls liver function. FASEB J. 2002:16:15-26.

[Author Network]

Michaela Collinsova,*3 Jana Strakova,* Jiri Jiracek,[dagger] and Timothy A. Garrow*4

* Dept of Nutriment Science and Human Nutrition, College of Illinois at Urbana-Champaign, Urbana, IL 61801 and [knife] Biological Chemistry Dept, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic,16610 Prague 6, Czech Republic

[Author Network]

3 Present address: Biological Chemistry Dept, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 16610 Prague 6, Czech Republic.

4 To whom letter must be addressed..